Kagami, M., Yanagisawa, A., Ota, M., Matsuoka, K., Nakamura, A., Matsubara, K., . . . Ogata, T. (2019). Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1: IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR. Clin Epigenetics.
Styl cytowania ChicagoKagami, Masayo, et al. "Temple Syndrome in a Patient With Variably Methylated CpGs At the Primary MEG3/DLK1: IG-DMR and Severely Hypomethylated CpGs At the Secondary MEG3:TSS-DMR." Clin Epigenetics 2019.
Styl cytowania MLAKagami, Masayo, et al. "Temple Syndrome in a Patient With Variably Methylated CpGs At the Primary MEG3/DLK1: IG-DMR and Severely Hypomethylated CpGs At the Secondary MEG3:TSS-DMR." Clin Epigenetics 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..